Rubio Rubio María Victoria, Lou Arnal Luis Miguel, Gimeno Orna José Antonio, Munguía Navarro Paula, Gutiérrez-Dalmau Alex, Lambán Ibor Elena, Paúl Ramos Javier, Pernaute Lavilla Raquel, Campos Gutiérrez Belén, San Juan Hernández-Franch Alberto
Servicio de Nefrología, Hospital Universitario Miguel Servet, Zaragoza, España.
Servicio de Nefrología, Hospital Universitario Miguel Servet, Zaragoza, España.
Nefrologia (Engl Ed). 2019 Mar-Apr;39(2):141-150. doi: 10.1016/j.nefro.2018.07.009. Epub 2018 Oct 26.
Conservative Management (CM) has become a therapeutic option in Advanced Chronic Kidney Disease in the elderly. However, there is a lack of evidence about prognosis of these patients in terms of survival and health related quality of life (HRQoL).
Establish predictive variables associated with mortality and analyse HRQoL in CM patients.
Prospective cohort study. An assessment of renal function parameters and a comprehensive geriatric assessment were made, including: analysis of comorbidity, functional, cognitive, fragility, nutritional, social and HRQoL status.
82 patients with a mean age of 84 years and significant pluripathology were studied: 56% had history of vascular event and Charlson >8. The mortality rate was 23/1,000 patients per month, with a homogeneous mortality rate after 6 months. Survival differed significantly depending on whether they presented with a previous vascular event (36.7 vs. 14.8; p=0.028), Charlson score ≥10 (42 vs. 17; p=0.002), functional status (48.4 vs. 19; p=0.002) and fragility (27 vs. 10; p=0.05). Mortality predictors included eGFR and proteinuria, the presence of previous vascular events, Charlson comorbidity score, malnutrition-inflammation parameters (albumin and MNA score), degree of dependency, physical HRQoL and increase of PTH level. The presence of previous vascular event, comorbidity, decreased albumin and elevated PTH were independent predictors of mortality. HRQoL remained stable over time and no significant worsening occurred during treatment.
Having knowledge of the factors associated with mortality and HRQoL assessment can be a useful tool to helping decision making during CM. Previous vascular events, comorbidity, decreased albumin and increased PTH were independent predictors of mortality.
保守治疗(CM)已成为老年晚期慢性肾脏病的一种治疗选择。然而,关于这些患者在生存和健康相关生活质量(HRQoL)方面的预后缺乏证据。
确定与死亡率相关的预测变量,并分析CM患者的HRQoL。
前瞻性队列研究。对肾功能参数进行评估,并进行全面的老年医学评估,包括:合并症分析、功能、认知、脆弱性、营养、社会和HRQoL状况。
研究了82例平均年龄84岁且有多种严重疾病的患者:56%有血管事件史,查尔森指数>8。死亡率为每月23/1000例患者,6个月后死亡率均匀。生存情况根据是否有既往血管事件(36.7对14.8;p=0.028)、查尔森评分≥10(42对17;p=0.002)、功能状态(48.4对19;p=0.002)和脆弱性(27对10;p=0.05)而有显著差异。死亡率预测因素包括估算肾小球滤过率(eGFR)和蛋白尿、既往血管事件的存在、查尔森合并症评分、营养不良-炎症参数(白蛋白和微型营养评定法(MNA)评分)、依赖程度、身体HRQoL和甲状旁腺激素(PTH)水平升高。既往血管事件的存在、合并症、白蛋白降低和PTH升高是死亡率的独立预测因素。HRQoL随时间保持稳定,治疗期间未出现显著恶化。
了解与死亡率相关的因素和HRQoL评估可能是CM期间帮助决策的有用工具。既往血管事件、合并症、白蛋白降低和PTH升高是死亡率的独立预测因素。